In:
APMIS, Wiley, Vol. 114, No. 5 ( 2006-05), p. 359-363
Abstract:
The purpose of the present study was to evaluate preoperative CA125 as a prognostic factor in stage I epithelial ovarian cancer (EOC). Preoperative serum CA125 levels from 118 women with FIGO (International Federation of Gynaecology and Obstetrics) stage I EOC were analysed and the prognostic value was evaluated and compared with other prognostic factors (age, grade, substages, histologic type). By the Kaplan‐Meier estimate we demonstrated that patients with stage I EOC and preoperative serum CA125 levels 〈 65 U/mL had a significantly longer survival compared to stage I EOC patients with preoperative serum CA125≥65 U/mL (p=0.01). The results from the present study may be useful for decision making respecting postoperative chemotherapy in stage I EOC patients. Serum CA125 levels might therefore be included as a prognostic factor in future clinical trials of stage I EOC.
Type of Medium:
Online Resource
ISSN:
0903-4641
,
1600-0463
DOI:
10.1111/apm.2006.114.issue-5
DOI:
10.1111/j.1600-0463.2006.apm_397.x
Language:
English
Publisher:
Wiley
Publication Date:
2006
detail.hit.zdb_id:
2098213-6
SSG:
12